Symbol="KDNY"
AssetType="Common Stock"
Name="Chinook Therapeutics Inc"
Description="Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision drugs for kidney disease. The company is headquartered in Seattle, Washington."
CIK="1435049"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="740 HEINZ AVENUE, BERKELEY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2708129000"
EBITDA="-228094000"
PERatio="None"
PEGRatio="None"
BookValue="5.32"
DividendPerShare="0"
DividendYield="0"
EPS="-3.24"
RevenuePerShareTTM="0.084"
ProfitMargin="0"
OperatingMarginTTM="-39.98"
ReturnOnAssetsTTM="-0.268"
ReturnOnEquityTTM="-0.569"
RevenueTTM="5849000"
GrossProfitTTM="-135083000"
DilutedEPSTTM="-3.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.411"
AnalystTargetPrice="40"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.9"
PriceToBookRatio="3.057"
EVToRevenue="19.67"
EVToEBITDA="-11.5"
Beta="0.673"
num_52WeekHigh="40.51"
num_52WeekLow="18.34"
num_50DayMovingAverage="39.16"
num_200DayMovingAverage="27.14"
SharesOutstanding="67050000"
DividendDate="2020-10-02"
ExDividendDate="None"
symbol="KDNY"
open="40.39"
high="40.39"
low="40.39"
price="40.39"
volume="0.00"
latest_trading_day="2023-08-11"
previous_close="40.39"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="51"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="1506385"
Change_recent_avg="0.02"
Delta_recent_avg="0.73"
Variance_recent_avg="0.36"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="1100"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_negative_thumbnail_id_2="498"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0107.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="704"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0004.jpeg"
image_positive_thumbnail_id_2="678"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
